W Bradford Smith is Officer of Homology Medicines, Inc.. Currently has a direct ownership of 14,219 shares of FIXX, which is worth approximately $0. The most recent transaction as insider was on Jan 09, 2023, when has been sold 3,729 shares (Common Stock) at a price of $1.39 per share, resulting in proceeds of $5,183. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 14.2K
0% 3M change
0% 12M change
Total Value Held $0

W Bradford Smith Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 09 2023
SELL
Open market or private sale
$5,183 $1.39 p/Share
3,729 Reduced 20.78%
14,219 Common Stock
Jan 01 2023
BUY
Exercise of conversion of derivative security
-
13,530 Added 42.98%
17,948 Common Stock
Jan 05 2022
SELL
Open market or private sale
$8,248 $3.78 p/Share
2,182 Reduced 33.06%
4,418 Common Stock
Jan 01 2022
BUY
Exercise of conversion of derivative security
-
6,600 Added 50.0%
6,600 Common Stock
Feb 08 2021
SELL
Open market or private sale
$192,375 $14.25 p/Share
13,500 Reduced 100.0%
0 Common Stock
Feb 08 2021
BUY
Exercise of conversion of derivative security
$8,640 $0.64 p/Share
13,500 Added 50.0%
13,500 Common Stock

Also insider at

LYRA
Lyra Therapeutics, Inc. Healthcare
WBS

W Bradford Smith

Officer
Bedford, MA

Track Institutional and Insider Activities on FIXX

Follow Homology Medicines, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FIXX shares.

Notify only if

Insider Trading

Get notified when an Homology Medicines, Inc. insider buys or sells FIXX shares.

Notify only if

News

Receive news related to Homology Medicines, Inc.

Track Activities on FIXX